A SERS quenching method for the sensitive determination of insulin.
Mahnaz D GholamiPrashant SonarGodwin A AyokoEmad L IzakePublished in: Drug testing and analysis (2020)
In this work, we utilise the disulphide bond structure of insulin and a new benzothiazole Raman probe for the detection of human insulin using surface-enhanced Raman spectroscopy (SERS). The disulphide bond structure of the insulin was reduced to generate free sulfhydryl terminal groups. When reacted with benzothiazole-functionalised gold nanoparticles, the reduced protein desorbs the Raman probe and causes its Raman signal intensity to quench. Using this approach, insulin was quantified in the concentration range of 1 × 10-14 -1 × 10-8 M by SERS quenching. The limit of quantification of insulin by the SERS quenching method was found to be 1 × 10-14 M (0.01 pM or 58 pg/L), which satisfies the requirements for monitoring its blood concentration in patients. Because many proteins and peptides have disulphide bonds in their molecular structures, the new SERS quenching method has a strong potential for the rapid determination of ultralow concentrations of proteins in formulations and biological fluids.
Keyphrases
- raman spectroscopy
- gold nanoparticles
- type diabetes
- label free
- glycemic control
- sensitive detection
- quantum dots
- endothelial cells
- end stage renal disease
- loop mediated isothermal amplification
- high resolution
- adipose tissue
- prognostic factors
- chronic kidney disease
- solid phase extraction
- metabolic syndrome
- small molecule
- risk assessment
- amino acid
- high intensity
- transition metal